Get Your FREE subscription today
Current Issues Past Issues Who We Are Resources Get Involved Glossary
 
From the Editor
Editor's Note
 
Memory News
New Memory Book
 
The Color of Risk
African-Americans are more likely to develop Alzheimer’s disease than whites. A new national program targets this dangerous disparity with community-based health education.
Go to Article >>
 
Caring for Culture
Hispanics in Milwaukee are improving services for elders with Alzheimer's disease by customizing care to cultural attitudes toward dementia and medicine.

Go to Article >>

 
Minority Report
Jennifer Manly’s research ensures that African-Americans and other racial and ethnic minorities are tested for dementia on a level playing field.
Go to Article >>
 
Memory Tip
Remembering the Future
Glossary
Clinical Trials
 

A clinical trial is a specific kind of research study that involves careful examination of the effects of a drug (or other treatment) administered to humans. Usually, some participants are given the test drug while others are given an alternative drug or a placebo; no participant knows which kind of treatment he or she is receiving. The researcher then determines whether the benefits of the test drug are significantly greater than the alternative drug or placebo.

For example, if a company has developed a new compound which it feels will prevent migraines better than an existing drug, or do just as well with fewer side effects, it may organize a clinical trial of the new compound. A group of migraine sufferers are recruited to participate, and they may be paid for their time. Each participant is asked to take a series of pills over a period of time -- without knowing whether they have been given is the test compound or the existing drug. During the study, each participant reports when and if they experience migraine. If the participants using the test compound report infrequent and mild headaches while the participants using the existing drug complain about frequent, severe migraines, then the researchers would conclude that the test compound is effective and should be made available for general medical use to treat and prevent migraines.

The goal of clinical trials is to determine both the efficacy of the drug and also whether it has side effects, toxicity and/or adverse interactions with other drugs. The U.S. government has very strict standards for these studies, and for how the results are to be evaluated, before a drug is approved for use in the United States. Every year, many compounds that are developed by pharmaceutical companies fail clinical trials, meaning that they do not pass the high standards for efficacy and safety, and never reach the market.

Further Reading:

Article : "THE BRAIN TREE"

Article : "ESTROGEN AND ALZHEIMER'S"

Article : "PUTTING GINGKO TO THE TEST"

 

by Catherine E. Myers. Copyright © 2006 Memory Loss and the Brain